Ivan Bergstein

This profile gathers the share dealings of Ivan Bergstein in Stemline Therapeutics Inc. Over a trading history stretching from 25 November 2013 to 10 June 2020, the count stands at 47 filings.

The open-market side counts 1 purchase for €17k alongside 32 sales for €5.1M. Taken together, the sales exceed the purchases by €5.1M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 12 share grants. Since January 2020: no purchases and 8 sales on the market.

Most recently, on 10 June 2020, the filings show a transaction in Stemline Therapeutics Inc. The last purchase on record was published on 3 September 2014, which is 4,433 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.